Tender Details

Country: USA
Summary: Notice of Intent to Sole Source supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA)
UST Ref No: 115811950
Deadline: 10 Mar 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: HT941025N0048
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
Notice of Intent to Sole Source HT941025N0048

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES.
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD-W), intends to award a one-time, firm fixed price contract to procure supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA) in accordance with the Federal Acquisition Regulation (FAR) 13.501(a) Sole Source/Brand Name acquisitions and FAR 13.1061(b)(1)(i), only one source being available to meet the Government-s needs, to:

Haemonetics Corporation
125 Summer Street
Boston, MA 02110-1613

The North American Industry Classification System (NAICS) code for this requirement is 621991 - Blood and Organ Banks; the business size standard is $40 million. The Product Service Code (PSC) is 6515 - Medical and Surgical Instruments, Equipment, and Supplies.

The objective of this sole source award is to procure supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA). Blood additive solutions preserve and extend the shelf life of red blood cells and platelets. They also help maintain the quality of the blood and reduce the risk of adverse reactions. Suggested source Haemonetics Corporation is the only viable source able to meet this requirement for blood additive solution for NHGA due to the highly specialized nature of their products. Additionally, Haemonetics blood additives is a proprietary disposable set to be used solely with Haemonetics ACP 215 device. The Haemonetics 250mL Anticoagulant Citrate Phosphate Double Dextrose (CP2D) and 250mL Additive Solution Formula 3 (AS-3) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components. Haemonetics is the OEM and only supplier for this requirement. There is no reasonable expectation of receiving quot...
Documents:

HT941025N0048-NOI-SS-NHGA-Haemonetics-Blood-Additi.pdf

SOW-NHGA-Haemonetics-blood-additive-solution.pdf

If you are registered member, kindly login to view full details of this tender notice:

Notice of Intent to Sole Source supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA) - USA Tender

The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA), a Government sector organization in USA, has announced a new tender for Notice of Intent to Sole Source supply of blood additive solution for use in Naval Hospital Guam-Agana (NHGA). This tender is published on USARFP under UST Ref No: 115811950 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-10.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.